D-erythro-Imidazoleglycerol phosphate monohydrate
CAS: 210241-69-3
Ref. 3D-FE22793
| 1mg | Discontinued | ||
| 2mg | Discontinued | ||
| 5mg | Discontinued | ||
| 10mg | Discontinued | ||
| 500µg | Discontinued |
Product Information
Name:
D-erythro-Imidazoleglycerol phosphate monohydrate
Synonyms:
- IGP
Description:
D-erythro-Imidazoleglycerol phosphate monohydrate (D-ERGP) is a drug that has been used for the treatment of chronic diseases. This drug is an analog of erythromycin, which has been shown to be active against some strains of bacteria resistant to tetracycline. D-ERGP is not a bacteriostatic agent and does not have significant interactions with other drugs. It has been shown to reduce blood pressure in animal models and human patients with diabetes mellitus, although it does not have significant effects on cholesterol levels or triglycerides. D-ERGP has also been shown to inhibit the growth of parasitoid wasps in vitro, but this effect is not observed in vivo. The catalytic mechanism of D-ERGP is unknown.
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:
Chemical properties
Molecular weight:
256.15 g/mol
Formula:
C6H11N2O6P·H2O
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
